Published in
Elsevier, Journal of Biological Chemistry, 39(288), p. 28068-28077, 2013
Links
- Elsevier
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
A Highly Selective Dual Insulin Receptor (IR)/Insulin-like Growth Factor 1 Receptor (IGF-1R) Inhibitor Derived from an Extracellular Signal-regulated Kinase (ERK) Inhibitor*
Journal article published in 2013 by
Theonie Anastassiadis,
Krisna C. Duong-Ly,
Sean W. Deacon,
Alec Lafontant,
Haiching,
Haiching Ma,
Karthik Devarajan,
Roland L. Dunbrack,
Jinhua Wu,
Jeffrey R. Peterson 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Background: IR/IGF-1R kinase inhibitors are promising therapeutic agents in cancer.